{"id":"https://openalex.org/W41146802","doi":null,"title":"Enhanced regional brain metabolic responses to benzodiazepines in cocaine abusers","display_name":"Enhanced regional brain metabolic responses to benzodiazepines in cocaine abusers","alternate_titles":[],"publication_year":1997,"publication_date":"1997-05-01","ids":{"openalex":"https://openalex.org/W41146802","mag":"41146802"},"language":"en","primary_location":{"id":"mag:41146802","doi":null,"is_oa":false,"landing_page_url":"https://www.osti.gov/scitech/biblio/563336-enhanced-regional-brain-metabolic-responses-benzodiazepines-cocaine-abusers","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null},"parent_works":[],"lineage":["https://openalex.org/W41146802"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002969658","display_name":"Nora D. Volkow","orcid":"https://orcid.org/0000-0001-6668-0908","observed_orcids":["https://orcid.org/0000-0001-6668-0908"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nora D. Volkow","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-6668-0908","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081492952","display_name":"Gene\u2010Jack Wang","orcid":"https://orcid.org/0000-0002-5017-9905","observed_orcids":["https://orcid.org/0000-0002-5017-9905"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G.J. Wang","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5112477718","display_name":"Joanna S. Fowler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joanna S. Fowler","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00090985,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.9429000020027161,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.03790000081062317,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.002400000113993883,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cocaine-dependence","display_name":"cocaine dependence","score":0.9449999928474426},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8610000014305115},{"id":"https://openalex.org/keywords/lorazepam","display_name":"lorazepam","score":0.9829999804496765},{"id":"https://openalex.org/keywords/gabaergic-dysfunction","display_name":"GABAergic dysfunction","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cerebral-glucose-metabolism","display_name":"brain glucose metabolism","score":0.8980000019073486},{"id":"https://openalex.org/keywords/striatum","display_name":"striatum","score":0.7099999785423279},{"id":"https://openalex.org/keywords/thalamus","display_name":"thalamus","score":0.9649999737739563},{"id":"https://openalex.org/keywords/cerebellum","display_name":"cerebellum","score":0.9990000128746033},{"id":"https://openalex.org/keywords/orbitofrontal-cortex","display_name":"orbitofrontal cortex","score":0.9210000038146973},{"id":"https://openalex.org/keywords/drug-induced-sleepiness","display_name":"drug-induced sleepiness","score":0.5699999928474426},{"id":"https://openalex.org/keywords/dopamine-d2-receptor","display_name":"dopamine D2 receptor","score":0.6949999928474426},{"id":"https://openalex.org/keywords/fdg-pet","display_name":"FDG-PET","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C2779706987","wikidata":"https://www.wikidata.org/wiki/Q408265","display_name":"Lorazepam","level":2,"score":0.9046065807342529},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.5880643725395203},{"id":"https://openalex.org/C2779177108","wikidata":"https://www.wikidata.org/wiki/Q18356742","display_name":"GABAergic","level":3,"score":0.5856992602348328},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.5151204466819763},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.476913183927536},{"id":"https://openalex.org/C2780062018","wikidata":"https://www.wikidata.org/wiki/Q1319792","display_name":"Striatum","level":3,"score":0.46544134616851807},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44253697991371155},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43257901072502136},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.4255877435207367},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.42093729972839355},{"id":"https://openalex.org/C99476002","wikidata":"https://www.wikidata.org/wiki/Q42297","display_name":"Analysis of variance","level":2,"score":0.4150053560733795},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4119741916656494},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.3625972867012024},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.32866138219833374},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.18337661027908325},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.08582845330238342},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:41146802","doi":null,"is_oa":false,"landing_page_url":"https://www.osti.gov/scitech/biblio/563336-enhanced-regional-brain-metabolic-responses-benzodiazepines-cocaine-abusers","pdf_url":null,"source":{"id":"https://openalex.org/S4210180780","display_name":"Journal of Nuclear Medicine","issn_l":"0161-5505","issn":["0161-5505","1535-5667","2159-662X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315767","host_organization_name":"Society of Nuclear Medicine and Molecular Imaging","host_organization_lineage":["https://openalex.org/P4310315767"],"host_organization_lineage_names":["Society of Nuclear Medicine and Molecular Imaging"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Journal of Nuclear Medicine","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2112332369","https://openalex.org/W205653918","https://openalex.org/W1997829966","https://openalex.org/W2090177918","https://openalex.org/W1559238190","https://openalex.org/W7099001218","https://openalex.org/W1734433368","https://openalex.org/W2098687626","https://openalex.org/W2162066549","https://openalex.org/W1995796138"],"abstract_inverted_index":{"While":[0],"dopamine":[1],"(DA)":[2],"appears":[3],"to":[4,44,54,73,75,132,147,153,258,272],"be":[5],"crucial":[6],"for":[7,50,245],"cocaine":[8,13,39,62,92,179,194,227,254,275],"reinforcement,":[9],"its":[10],"involvement":[11],"in":[12,26,38,61,163,166,171,178,182,185,193,205,211,253,260,274,284],"addiction":[14],"is":[15,278],"much":[16],"less":[17],"clear.":[18],"Using":[19],"PET":[20,103],"we":[21,67],"have":[22],"shown":[23],"persistent":[24],"reductions":[25],"striatal":[27],"DA":[28,51],"D2":[29],"receptors":[30],"(which":[31],"arc":[32],"predominantly":[33],"located":[34],"on":[35],"GABA":[36,78],"cells)":[37],"abusers.":[40,63],"This":[41],"finding":[42],"coupled":[43],"GABA`s":[45],"role":[46],"as":[47],"an":[48,269],"effector":[49],"led":[52],"us":[53],"investigate":[55],"if":[56],"there":[57],"were":[58,151,175,208,256],"GABAergic":[59,82,282],"abnormalities":[60],"In":[64],"this":[65],"study":[66],"measured":[68],"regional":[69,206],"brain":[70,172,188,243],"metabolic":[71,249],"responses":[72],"lorazepam,":[74],"indirectly":[76],"assess":[77],"function":[79,283],"(benzodiazepines":[80],"facilitate":[81],"neurotransmission).":[83],"Methods:":[84],"The":[85,113,149,241],"experimental":[86],"subjects":[87,150],"consisted":[88],"of":[89,110,121,125,139,226,230],"12":[90],"active":[91],"abusers":[93,164,180,195,228,255,276],"and":[94,134,221],"32":[95],"age":[96],"matched":[97],"controls.":[98,183],"Each":[99],"subject":[100],"underwent":[101],"two":[102],"FDG":[104,115],"scans":[105],"obtained":[106,118],"within":[107],"1":[108],"week":[109],"each":[111],"other.":[112],"first":[114],"scan":[116],"was":[117,160,262],"after":[119,137],"administration":[120,138],"placebo":[122],"(3":[123],"cc":[124],"saline":[126],"solution)":[127],"given":[128,143],"40-50":[129,144],"minutes":[130,145],"prior":[131,146],"FDG;":[133],"the":[135,154,247,263],"second":[136],"lorazepam":[140,252],"(30":[141],"{mu}g/kg)":[142],"FDG.":[148],"blind":[152],"drugs":[155],"received.":[156],"Results:":[157],"Lorazepam-induced":[158,169,203],"sleepiness":[159],"significantly":[161,176,209],"greater":[162],"than":[165,181,229],"controls":[167,186,231,261],"(p<0.001).":[168],"decreases":[170],"glucose":[173],"metabolism":[174,189,207],"larger":[177,210],"Whereas":[184],"whole":[187],"decreased":[190,197],"13{+-}7":[191],"%,":[192],"it":[196],"21{+-}13":[198],"%more\u00a0\u00bb":[199],"(p":[200,213,218,223],"<":[201,214,219,224],"0.05).":[202],"decrements":[204],"striatum":[212],"0.0":[215],"1),":[216],"thalamus":[217],"0.01)":[220],"cerebellum":[222],"0.005)":[225],"(ANOVA":[232],"diagnosis":[233],"by":[234,251],"condition":[235],"(placebo":[236],"versus":[237],"lorazepam)":[238],"interaction":[239],"effect).":[240],"only":[242],"region":[244],"which":[246,277],"absolute":[248],"changes-induced":[250],"equivalent":[257],"those":[259],"orbitofrontal":[264],"cortex.":[265],"These":[266],"results":[267],"document":[268],"accentuated":[270],"sensitivity":[271],"benzodiazepines":[273],"compatible":[279],"with":[280],"disrupted":[281],"these":[285],"patients.\u00ab\u00a0less":[286]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W41146802","counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2016-06-24T00:00:00"}
